Pucotenlimab: clinical trials recruiting now
4
Recruiting trials
11
Conditions studied
0
US states with sites
1
Countries
Phase breakdown
Phase 1 1
Phase 2 4
Conditions being studied
| Condition | Trials |
|---|---|
| Colorectal cancer | 2 |
| Colorectal Cancer (CRC) | 1 |
| LDRT | 1 |
| Melanoma | 1 |
| Melanoma Metastatic | 1 |
| NRAS Mutation | 1 |
| PD-1 Inhibitor | 1 |
| PD-L1 | 1 |
| Pancreatic Cancer | 1 |
| Proterizumab | 1 |
| Rectal Cancer | 1 |
Recruiting trials involving Pucotenlimab
- LDRT Combined With Pucotenlimab and Standard Therapy for Advanced Pancreatic Cancer: A Single-Arm Study
- Low-Dose Radiotherapy to Sensitize Pucotenlimab Plus CAPEOX for pMMR Locally Advanced Rectal Cancer
- Pucotenlimab Plus Radiotherapy and Chemotherapy for Neoadjuvant Treatment of Locally Advanced Rectal Cance(PUCRT)
- Tunlametinib in Combination With Pucotenlimab and Hydroxychloroquine in NRAS Mutant Melanoma
Common questions
How many recruiting trials involve Pucotenlimab?
4 recruiting trials across 11 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.